Pedro Beltran

CIK: 0002058152

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BBOT

BridgeBio Oncology Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

BBOT
BridgeBio Oncology Therapeutics, Inc.
Oct 1, 2026
Tax Payment(F)
Direct
1K shares at avg. $3.94$4K
BBOT
BridgeBio Oncology Therapeutics, Inc.
Jul 1, 2026
Tax Payment(F)
Direct
1K shares at avg. $7.80$8K
BBOT
BridgeBio Oncology Therapeutics, Inc.
May 10, 2026
Award(A)
Stock Option (Right to Buy)
Direct
1.1M shares-
BBOT
BridgeBio Oncology Therapeutics, Inc.
Apr 1, 2026
Tax Payment(F)
Direct
1K shares at avg. $9.03$9K
BBOT
BridgeBio Oncology Therapeutics, Inc.
Mar 10, 2026
Award(A)
Direct
46.7K shares-
BBOT
BridgeBio Oncology Therapeutics, Inc.
Aug 26, 2025
Award(A)
Stock Option (Right to Buy)
Direct
357.2K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	BBOT BridgeBio Oncology Therapeutics, Inc.	Tax Payment(F)	1,047	$3.94	$4,125	Direct
Jul 1, 2026	BBOT BridgeBio Oncology Therapeutics, Inc.	Tax Payment(F)	1,047	$7.80	$8,167	Direct
May 10, 2026	BBOT BridgeBio Oncology Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	1,103,837	-	-	Direct
Apr 1, 2026	BBOT BridgeBio Oncology Therapeutics, Inc.	Tax Payment(F)	1,047	$9.03	$9,454	Direct
Mar 10, 2026	BBOT BridgeBio Oncology Therapeutics, Inc.	Award(A)	46,670	-	$0	Direct
Aug 26, 2025	BBOT BridgeBio Oncology Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	357,177	-	-	Direct

1-6 of 6 transactions

About Beltran Pedro

Beltran Pedro (SEC CIK 0002058152) files insider reports with the SEC as President and CEO of BridgeBio Oncology Therapeutics, Inc. (BBOT).

Signal8 holds 7 ownership filings by Beltran Pedro (1 Form 3, 6 Form 4), filed between Aug 18, 2025 and Oct 5, 2026. Those filings report 6 transactions, from Aug 26, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Beltran Pedro's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Beltran Pedro

Oct 1, 2026: Tax withholding of BBOT shares (Form 4, code F).
Jul 1, 2026: Tax withholding of BBOT shares (Form 4, code F).
May 10, 2026: Grant or award of BBOT derivative securities (Form 4, code A).
Apr 1, 2026: Tax withholding of BBOT shares (Form 4, code F).
Mar 10, 2026: Grant or award of BBOT shares (Form 4, code A).

Other insiders filing for BridgeBio Oncology Therapeutics, Inc. (BBOT)

Cobo Marc, Principal Accounting Officer
Elmelech Idan, COO & Principal Financial Ofcr
Ben Yong, Chief Med & Dev Officer
Chen Bihua, Director
Tipirneni Praveen P., Director
MCCORMICK FRANK, Director

How to read Form 4 transaction codes